Omega-3 PUFAs Suppress IL-1β-Induced Hyperactivity of Immunoproteasomes in Astrocytes

Int J Mol Sci. 2021 May 21;22(11):5410. doi: 10.3390/ijms22115410.

Abstract

The role of immunoproteasome (iP) in astroglia, the cellular component of innate immunity, has not been clarified. The results so far indicate that neuroinflammation, a prominent hallmark of Alzheimer's disease, strongly activates the iP subunits expression. Since omega-3 PUFAs possess anti-inflammatory and pro-resolving activity in the brain, we investigated the effect of DHA and EPA on the gene expression of constitutive (β1 and β5) and inducible (iβ1/LMP2 and iβ5/LMP7) proteasome subunits and proteasomal activity in IL-1β-stimulated astrocytes. We found that both PUFAs downregulated the expression of IL-1β-induced the iP subunits, but not the constitutive proteasome subunits. The chymotrypsin-like activity was inhibited in a dose-dependent manner by DHA, and much strongly in the lower concentration by EPA. Furthermore, we established that C/EBPα and C/EBPβ transcription factors, being the cis-regulatory element of the transcription complex, frequently activated by inflammatory mediators, participate in a reduction in the iP subunits' expression. Moreover, the expression of connexin 43 the major gap junction protein in astrocytes, negatively regulated by IL-1β was markedly increased in PUFA-treated cells. These findings indicate that omega-3 PUFAs attenuate inflammation-induced hyperactivity of iPs in astrocytes and have a beneficial effect on preservation of interastrocytic communication by gap junctions.

Keywords: C/EBPs; astrocytes; connexin 43; docosahexaenoic acid; eicosapentaenoic acid; immunoproteasome.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Astrocytes / drug effects*
  • Astrocytes / metabolism
  • CCAAT-Enhancer-Binding Protein-alpha / metabolism
  • CCAAT-Enhancer-Binding Protein-beta / metabolism
  • Connexin 43 / metabolism
  • Docosahexaenoic Acids / pharmacology
  • Down-Regulation / drug effects
  • Eicosapentaenoic Acid / pharmacology
  • Fatty Acids, Omega-3 / pharmacology*
  • Fatty Acids, Unsaturated / metabolism
  • Gap Junctions / drug effects
  • Gap Junctions / metabolism
  • Gene Expression / drug effects
  • Inflammation / metabolism
  • Interleukin-1beta / metabolism*
  • Proteasome Endopeptidase Complex / metabolism*
  • Rats
  • Signal Transduction / drug effects

Substances

  • Anti-Inflammatory Agents
  • CCAAT-Enhancer-Binding Protein-alpha
  • CCAAT-Enhancer-Binding Protein-beta
  • Connexin 43
  • Fatty Acids, Omega-3
  • Fatty Acids, Unsaturated
  • IL1B protein, rat
  • Interleukin-1beta
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid
  • Proteasome Endopeptidase Complex